Clinical Trial Update: Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial studying pemetrexed with gemcitabine or with carboplatin in advanced malignant pleural mesothelioma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2010-03-04